Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience

INTRODUCTION: Hepatitis C virus (HCV) infection has detrimental effects on patient and graft survival after kidney transplantation. In the pre‐direct‐acting antiviral (DAA) era, treatment of HCV infection was associated with low response rates, poor tolerance, and increased risk of allograft rejecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkadi, Mohamad M., Abuhelaiqa, Essa A., Elshirbeny, Mostafa F., Hamdi, Ahmed F., Fituri, Omar M., Asim, Muhammad, Alkaabi, Saad R., Derbala, Moutaz F., Jarman, Mona E., Ashour, Adel M., Nauman, Awais, Al Maslamani, Yousuf K., Butt, Adeel A., Al‐Malki, Hassan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860605/
https://www.ncbi.nlm.nih.gov/pubmed/33264509
http://dx.doi.org/10.1002/iid3.386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860605/
https://www.ncbi.nlm.nih.gov/pubmed/33264509
http://dx.doi.org/10.1002/iid3.386

Ejemplares similares